However, despite affinity, albeit lower, of tirzepatide for the GLP-1 receptor, tirzepatide had no effect on body weight, food intake, fasting insulin, endogenous glucose production and insulin-stimulated glucose uptake in skeletal muscle and subcutaneous white adipose tissue of GLP-1 receptor knockout mice [89]
reversing MAFLD
At 26 and 52 weeks, BMI gains were 0.70 and 0.82 kg/m, respectively
Register for the webinar today by clicking here.
In its natural state, GLP-1 is highly efficient but short-lived
The Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)